It is tempting to speculate that inhibiting CENP-A deposition will impede progression in an existing tumor while inducing milder consequences in surrounding healthy tissue that has both a lower rate of proliferation and a functional p53 response. The gene discussed is CENPA; the disease is neoplasm.